Skip to main content
Erschienen in: European Radiology 12/2022

21.06.2022 | Cardiac

Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study

verfasst von: Meng-Meng Yu, Xiang-Lin Tang, Xin Zhao, Yin-Yin Chen, Zhi-Han Xu, Qi-Bing Wang, Meng-Su Zeng

Erschienen in: European Radiology | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The presence of non-alcoholic fatty liver disease (NAFLD) has been associated with major adverse cardiovascular events (MACEs); however, the mechanisms that initiate the risk for MACEs in patients with NAFLD remain unknown. We sought to investigate whether plaque progression (PP), determined by coronary CT angiography (CCTA), moderate the relationship between NAFLD and MACEs.

Methods

A total of 1683 asymptomatic participants (mean age, 63.3 ± 9.4 [range, 38–85] years; 1117 men) who underwent baseline and follow-up CCTA examination were prospectively included in our study. All of the participants were divided into the NAFLD and non-NAFLD groups. PP was determined by follow-up CCTA. The primary endpoint was MACEs, defined as the composite of all-cause death, nonfatal myocardial infarction, and unplanned hospitalization for acute coronary syndrome leading to revascularization.

Results

At follow-up CCTA, participants with NAFLD showed higher incidence of PP than those without [33.0% (248/752) vs. 16.6% (155/931), p < 0.001]. Compared with non-NAFLD participants, participants with NAFLD had a lower 9.7-year event-free survival rate (80.9 vs. 66.4%, log-rank p < 0.001). Cox regression analysis revealed NAFLD was significantly associated with MACEs (HR = 1.63, 95% CI: 1.28 to 2.06, p < 0.001) after adjusting for covariables. However, this association was no longer significant after adjustment for PP (HR = 1.10, 95% CI: 0.84 to 1.45, p = 0.496). The mediation analysis revealed that PP had a significant indirect effect (β = 0.0587, 95% CI: 0.0424 to 0.08, p < 0.001) and mediated 99.8% (p = 0.002) for the relationship between NAFLD and MACEs.

Conclusions

Plaque progression, identified by follow-up CCTA, mediates the relationship between NAFLD and MACEs.

Key Points

  • The incidence of CCTA–identified PP was higher for participants with NAFLD than those without NAFLD (248/752 [33.0%] vs. 155/931 [16.6%], p < 0.001).
  • Participants with NAFLD had a lower 9.7-year event-free survival rate than those without NAFLD (66.4% vs. 80.9%, log-rank p < 0.001).
  • The mediation analysis revealed that PP had a significant indirect effect (β = 0.0587, 95% CI: 0.0424 to 0.08, p < 0.001) and mediated 99.8% (p = 0.002) for the relationship between NAFLD and MACEs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328–357CrossRefPubMed Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328–357CrossRefPubMed
3.
Zurück zum Zitat Pais R, Redheuil A, Cluzel P, Ratziu V, Giral P (2019) Relationship among fatty liver, specific and multiple-site atherosclerosis, and 10-year Framingham score. Hepatology 69:1453–1463CrossRefPubMed Pais R, Redheuil A, Cluzel P, Ratziu V, Giral P (2019) Relationship among fatty liver, specific and multiple-site atherosclerosis, and 10-year Framingham score. Hepatology 69:1453–1463CrossRefPubMed
4.
Zurück zum Zitat Sinn DH, Kang D, Chang Y et al (2017) Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. Gut 66:323–329CrossRefPubMed Sinn DH, Kang D, Chang Y et al (2017) Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. Gut 66:323–329CrossRefPubMed
5.
Zurück zum Zitat Kim D, Choi SY, Park EH et al (2012) Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 56:605–613CrossRefPubMed Kim D, Choi SY, Park EH et al (2012) Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 56:605–613CrossRefPubMed
6.
Zurück zum Zitat Lee SB, Park GM, Lee JY et al (2018) Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study. J Hepatol 68:1018–1024CrossRefPubMed Lee SB, Park GM, Lee JY et al (2018) Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study. J Hepatol 68:1018–1024CrossRefPubMed
8.
Zurück zum Zitat Labenz C, Huber Y, Michel M et al (2020) Impact of NAFLD on the incidence of cardiovascular diseases in a primary care population in Germany. Dig Dis Sci 65:2112–2119CrossRefPubMed Labenz C, Huber Y, Michel M et al (2020) Impact of NAFLD on the incidence of cardiovascular diseases in a primary care population in Germany. Dig Dis Sci 65:2112–2119CrossRefPubMed
9.
Zurück zum Zitat Puchner SB, Lu MT, Mayrhofer T et al (2015) High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology 274:693–701CrossRefPubMed Puchner SB, Lu MT, Mayrhofer T et al (2015) High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology 274:693–701CrossRefPubMed
10.
Zurück zum Zitat Motoyama S, Ito H, Sarai M et al (2015) Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol 66:337–346CrossRefPubMed Motoyama S, Ito H, Sarai M et al (2015) Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol 66:337–346CrossRefPubMed
11.
Zurück zum Zitat Yu M, Li W, Lu Z, Wei M, Yan J, Zhang J (2018) Quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis predicts lesion volume progression and long-term prognosis: a serial CT follow-up study. Int J Cardiol 264:181–186CrossRefPubMed Yu M, Li W, Lu Z, Wei M, Yan J, Zhang J (2018) Quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis predicts lesion volume progression and long-term prognosis: a serial CT follow-up study. Int J Cardiol 264:181–186CrossRefPubMed
12.
Zurück zum Zitat Smit JM, van Rosendael AR, El Mahdiui M et al (2020) Impact of clinical characteristics and statins on coronary plaque progression by serial computed tomography angiography. Circ Cardiovasc Imaging 13:e009750CrossRefPubMed Smit JM, van Rosendael AR, El Mahdiui M et al (2020) Impact of clinical characteristics and statins on coronary plaque progression by serial computed tomography angiography. Circ Cardiovasc Imaging 13:e009750CrossRefPubMed
13.
Zurück zum Zitat Budoff MJ, Dowe D, Jollis JG et al (2008) Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 52:1724–1732CrossRefPubMed Budoff MJ, Dowe D, Jollis JG et al (2008) Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 52:1724–1732CrossRefPubMed
14.
Zurück zum Zitat Lee SE, Chang HJ, Sung JM et al (2018) Effects of statins on coronary atherosclerotic plaques: the PARADIGM Study. JACC Cardiovasc Imaging 11:1475–1484CrossRefPubMed Lee SE, Chang HJ, Sung JM et al (2018) Effects of statins on coronary atherosclerotic plaques: the PARADIGM Study. JACC Cardiovasc Imaging 11:1475–1484CrossRefPubMed
15.
Zurück zum Zitat Cury RC, Abbara S, Achenbach S et al (2016) CAD-RADS™: Coronary Artery Disease - Reporting and Data System: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Am Coll Radiol 13:1458–1466 e1459CrossRefPubMed Cury RC, Abbara S, Achenbach S et al (2016) CAD-RADS™: Coronary Artery Disease - Reporting and Data System: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Am Coll Radiol 13:1458–1466 e1459CrossRefPubMed
16.
Zurück zum Zitat Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312CrossRefPubMed Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312CrossRefPubMed
17.
Zurück zum Zitat Speliotes EK, Massaro JM, Hoffmann U et al (2008) Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 23:894–899CrossRefPubMedPubMedCentral Speliotes EK, Massaro JM, Hoffmann U et al (2008) Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 23:894–899CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hicks KA, Tcheng JE, Bozkurt B et al (2015) 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66:403–469CrossRefPubMed Hicks KA, Tcheng JE, Bozkurt B et al (2015) 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66:403–469CrossRefPubMed
19.
Zurück zum Zitat Baron RM, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182CrossRefPubMed Baron RM, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182CrossRefPubMed
20.
Zurück zum Zitat Preacher KJ, Hayes AF (2004) SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 36:717–731CrossRefPubMed Preacher KJ, Hayes AF (2004) SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 36:717–731CrossRefPubMed
21.
Zurück zum Zitat Kim U, Leipsic JA, Sellers SL et al (2018) Natural history of diabetic coronary atherosclerosis by quantitative measurement of serial coronary computed tomographic angiography: results of the PARADIGM Study. JACC Cardiovasc Imaging 11:1461–1471CrossRefPubMed Kim U, Leipsic JA, Sellers SL et al (2018) Natural history of diabetic coronary atherosclerosis by quantitative measurement of serial coronary computed tomographic angiography: results of the PARADIGM Study. JACC Cardiovasc Imaging 11:1461–1471CrossRefPubMed
22.
Zurück zum Zitat Niikura T, Imajo K, Ozaki A et al (2020) Coronary artery disease is more severe in patients with non-alcoholic steatohepatitis than fatty liver. Diagnostics (Basel) 10 Niikura T, Imajo K, Ozaki A et al (2020) Coronary artery disease is more severe in patients with non-alcoholic steatohepatitis than fatty liver. Diagnostics (Basel) 10
23.
Zurück zum Zitat Idilman IS, Akata D, Hazirolan T, Doganay Erdogan B, Aytemir K, Karcaaltincaba M (2015) Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2. J Diabetes 7:279–286CrossRefPubMed Idilman IS, Akata D, Hazirolan T, Doganay Erdogan B, Aytemir K, Karcaaltincaba M (2015) Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2. J Diabetes 7:279–286CrossRefPubMed
24.
Zurück zum Zitat Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z (2016) Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep 6:33386CrossRefPubMedPubMedCentral Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z (2016) Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep 6:33386CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Villanova N, Moscatiello S, Ramilli S et al (2005) Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42:473–480CrossRefPubMed Villanova N, Moscatiello S, Ramilli S et al (2005) Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42:473–480CrossRefPubMed
26.
Zurück zum Zitat Bieghs V, Rensen PC, Hofker MH, Shiri-Sverdlov R (2012) NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages. Atherosclerosis 220:287–293CrossRefPubMed Bieghs V, Rensen PC, Hofker MH, Shiri-Sverdlov R (2012) NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages. Atherosclerosis 220:287–293CrossRefPubMed
27.
Zurück zum Zitat Speliotes EK, Yerges-Armstrong LM, Wu J et al (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 7:e1001324CrossRefPubMedPubMedCentral Speliotes EK, Yerges-Armstrong LM, Wu J et al (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 7:e1001324CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C (2016) Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 65:589–600CrossRefPubMed Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C (2016) Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 65:589–600CrossRefPubMed
29.
Zurück zum Zitat Zeb I, Li D, Budoff MJ et al (2016) Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis. J Am Coll Cardiol 67:1965-1966 Zeb I, Li D, Budoff MJ et al (2016) Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis. J Am Coll Cardiol 67:1965-1966
30.
Zurück zum Zitat Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226–235CrossRefPubMed Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226–235CrossRefPubMed
31.
Zurück zum Zitat Zaman T, Agarwal S, Anabtawi AG et al (2012) Angiographic lesion severity and subsequent myocardial infarction. Am J Cardiol 110:167–172CrossRefPubMed Zaman T, Agarwal S, Anabtawi AG et al (2012) Angiographic lesion severity and subsequent myocardial infarction. Am J Cardiol 110:167–172CrossRefPubMed
32.
Zurück zum Zitat Yokoya K, Takatsu H, Suzuki T et al (1999) Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year. Circulation 100:903–909CrossRefPubMed Yokoya K, Takatsu H, Suzuki T et al (1999) Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year. Circulation 100:903–909CrossRefPubMed
33.
Zurück zum Zitat Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J (2019) From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol 74:1608–1617CrossRefPubMed Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J (2019) From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol 74:1608–1617CrossRefPubMed
34.
Zurück zum Zitat Ahmadi A, Narula J (2017) Primary and secondary prevention, or subclinical and clinical atherosclerosis. JACC Cardiovasc Imaging 10:447–450CrossRefPubMed Ahmadi A, Narula J (2017) Primary and secondary prevention, or subclinical and clinical atherosclerosis. JACC Cardiovasc Imaging 10:447–450CrossRefPubMed
Metadaten
Titel
Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study
verfasst von
Meng-Meng Yu
Xiang-Lin Tang
Xin Zhao
Yin-Yin Chen
Zhi-Han Xu
Qi-Bing Wang
Meng-Su Zeng
Publikationsdatum
21.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08904-2

Weitere Artikel der Ausgabe 12/2022

European Radiology 12/2022 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.